Kamada (KMDA) EPS (Diluted) Growth (3y) (2018 - 2026)
Kamada (KMDA) EPS (Diluted) Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kamada | 473.85 Mn | 444.38 Mn | 22.47 Mn | 57.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.27% |
| Mar 31, 2026 | 1,314.17% |
| Dec 31, 2025 | 11.83% |
| Sep 30, 2025 | 2,027.34% |
| Jun 30, 2025 | -89.24% |
| Mar 31, 2025 | 57.85% |
| Dec 31, 2024 | 29.64% |
| Sep 30, 2024 | 56.84% |
| Jun 30, 2024 | -84.23% |
| Mar 31, 2024 | -8.07% |
| Dec 31, 2023 | 36.53% |
| Sep 30, 2023 | -24.72% |
| Jun 30, 2023 | -22.03% |
| Mar 31, 2023 | -26.00% |
| Dec 31, 2022 | -18.17% |
| Sep 30, 2022 | -95.47% |
| Jun 30, 2022 | 719.34% |
| Mar 31, 2022 | -30.57% |
| Dec 31, 2021 | -30.93% |
| Sep 30, 2021 | -31.26% |